SOLARANSE28 January 2019

Solara Active Pharma Sciences Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re...

Solara Active Pharma Sciences Limited

Communication Address: Sciara Active Pharma Sciences Limited Batra Centre No. 28, Sardar Patel Road, Post Box 2630 Guindy, Chennai - 600 032. India Tel : +91 44 43446700, 22207500 Fax : +91 44 22350278

January 28, 2019

The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai - 400 001

The National Stock Exchange oflndia Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai - 400 051

Scrip Code: 541540

Dear Sir/ Madam,

Scrip Code: SOLARA

Sub: Intimation of Analysts / Institutional Investors Conference Call

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the Analysts/ Institutional Investors on Thursday, January 31, 2019 to discuss its Q3 FY19 financial results. The conference call details are as follows:

Event

Post Results Q3 FY 19 Conference Call

Date & Time

Phone Numbers

January 31, 2019 at 3:00 p.m. 1ST +91 22 62801346 +91 22 71158247

URL for prior (early) registration http://services.chornscalJ.in/dinmondpass/registration/register?confirmationNumber=79489&linkSecu rilv. tring=la8f8ce6

This is for your information and records.

Thanking you,

Yours faithfully, For Solara Active Pharma Sciences Limited

✓�y

S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN : U24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai- 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 I Fax: 91-22-2789 2942

← All TranscriptsSOLARA Stock Page →